학술논문

Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
Document Type
Article
Source
In: Clinical Gastroenterology and Hepatology. (Clinical Gastroenterology and Hepatology, August 2023, 21(9):2338-2346.e3)
Subject
Language
English
ISSN
15427714
15423565